Stay updated on PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.

Latest updates to the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page
- Check5 days agoChange DetectedA minor version update from v3.3.3 to v3.3.4 is shown; no visible changes to the study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedGuangdong has been added to the Locations section as a new trial site. This update expands the study's geographic reach and provides participation details for the new site.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page revision label was updated to v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

- Check55 days agoChange DetectedA new note indicates PubMed publications are automatically filled and may not relate to the study, and the revision stamp updated to v3.3.1, replacing the older v3.2.0 wording.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding status notice on the page has been removed, and the core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedStudy Details page shows a visual/layout update (reorganized panels and header styling) with no changes to the study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.